Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (99)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hou, S.-M.
Right arrow Articles by Hemminki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hou, S.-M.
Right arrow Articles by Hemminki, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 23, No. 4, 599-603, April 2002
© 2002 Oxford University Press


MOLECULAR EPIDEMIOLOGY

The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk

Sai-Mei Hou1,3, Susann Fält1, Sabrina Angelini1, Ke Yang1, Fredrik Nyberg2, Bo Lambert1 and Kari Hemminki1

1 Department of Biosciences at Novum, Karolinska Institute, S-141 57 Huddinge, Sweden and
2 Division of Environmental Epidemiology, Institute of Environmental Medicine, Karolinska Institute, Box 210, S-171 77 Stockholm, Sweden

Abstract

The DNA repair protein xeroderma pigmentosum complementation group D (XPD) is involved in the nucleotide excision repair of DNA lesions induced by many tobacco and environmental carcinogens. In order to study the functional impact of the common polymorphisms in XPD exon 10 (G > A, Asp312Asn) and exon 23 (A > C, Lys751Gln), we have genotyped 185 Swedish lung cancer cases (97 smokers and 88 never-smokers) and 162 matched population controls (83 smokers and 79 never-smokers). Presence of one or two variant alleles was associated with increased risk for lung cancer among never-smokers only, in particular younger (<70 years) never-smokers [odds ratio (OR) = 2.6, 95% confidence interval (CI) = 1.1–6.5 for exon 10; OR = 3.2, 95% CI = 1.3–8.0 for exon 23, adjusted for age, gender and environmental tobacco smoke]. Aromatic DNA adduct level (AL) in peripheral lymphocytes was found to be similar between cases and controls, but significantly increased by current or recent smoking. Overall, there was a significant trend for increasing AL with increasing number of variant alleles in exon 10 (P = 0.02) or in exon 23 (P = 0.001). In addition, subjects with the combined exon 10 AA and exon 23 CC genotype showed a significantly higher AL compared with all those with any of the other genotypes (P = 0.02). We conclude that the XPD variant alleles may be associated with reduced repair of aromatic DNA adducts in general and increased lung cancer risk among never-smokers.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JCOHome page
D. R. Gandara, T. Kawaguchi, J. Crowley, J. Moon, K. Furuse, M. Kawahara, S. Teramukai, Y. Ohe, K. Kubota, S. K. Williamson, et al.
Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non-Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics
J. Clin. Oncol., July 20, 2009; 27(21): 3540 - 3546.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Michiels, A. Laplanche, T. Boulet, P. Dessen, B. Guillonneau, A. Mejean, F. Desgrandchamps, M. Lathrop, A. Sarasin, and S. Benhamou
Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk
Carcinogenesis, May 1, 2009; 30(5): 763 - 768.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. R. McWilliams, W. R. Bamlet, M. de Andrade, D. N. Rider, J. M. Cunningham, and G. M. Petersen
Nucleotide Excision Repair Pathway Polymorphisms and Pancreatic Cancer Risk: Evidence for role of MMS19L
Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1295 - 1302.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. Wang, D. Chang, F.-l. Hu, H. Sui, B. Han, D.-d. li, and Y.-s. Zhao
DNA Repair Gene XPD Polymorphisms and Cancer Risk: A Meta-analysis Based on 56 Case-Control Studies
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 507 - 517.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. D. Crew, M. D. Gammon, M. B. Terry, F. F. Zhang, L. B. Zablotska, M. Agrawal, J. Shen, C.-M. Long, S. M. Eng, S. K. Sagiv, et al.
Polymorphisms in Nucleotide Excision Repair Genes, Polycyclic Aromatic Hydrocarbon-DNA Adducts, and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2033 - 2041.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
S. Mahabir, C. C Abnet, Y.-L. Qiao, L. D Ratnasinghe, S. M Dawsey, Z.-W. Dong, P. R Taylor, and S. D Mark
A prospective study of polymorphisms of DNA repair genes XRCC1, XPD23 and APE/ref-1 and risk of stroke in Linxian, China
J Epidemiol Community Health, August 1, 2007; 61(8): 737 - 741.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. F. Giachino, P. Ghio, S. Regazzoni, G. Mandrile, S. Novello, G. Selvaggi, D. Gregori, M. DeMarchi, and G. V. Scagliotti
Prospective Assessment of XPD Lys751Gln and XRCC1 Arg399Gln Single Nucleotide Polymorphisms in Lung Cancer
Clin. Cancer Res., May 15, 2007; 13(10): 2876 - 2881.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. G. Schwartz, G. M. Prysak, C. H. Bock, and M. L. Cote
The molecular epidemiology of lung cancer
Carcinogenesis, March 1, 2007; 28(3): 507 - 518.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Shen, M. Desai, M. Agrawal, D. O. Kennedy, R. T. Senie, R. M. Santella, and M. B. Terry
Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer.
Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1614 - 1619.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Ye, R. Kumar, G. Bacova, J. Lagergren, K. Hemminki, and O. Nyren
The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden
Carcinogenesis, September 1, 2006; 27(9): 1835 - 1841.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Z. Hu, L. Xu, M. Shao, J. Yuan, Y. Wang, F. Wang, W. Yuan, J. Qian, H. Ma, Y. Wang, et al.
Polymorphisms in the Two Helicases ERCC2/XPD and ERCC3/XPB of the Transcription Factor IIH Complex and Risk of Lung Cancer: A Case-Control Analysis in a Chinese Population.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1336 - 1340.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. E. Mechanic, R. C. Millikan, J. Player, A. R. de Cotret, S. Winkel, K. Worley, K. Heard, K. Heard, C.-K. Tse, and T. Keku
Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study
Carcinogenesis, July 1, 2006; 27(7): 1377 - 1385.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Zienolddiny, D. Campa, H. Lind, D. Ryberg, V. Skaug, L. Stangeland, D. H. Phillips, F. Canzian, and A. Haugen
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
Carcinogenesis, March 1, 2006; 27(3): 560 - 567.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Bigler, C. M. Ulrich, T. Kawashima, J. Whitton, and J. D. Potter
DNA Repair Polymorphisms and Risk of Colorectal Adenomatous or Hyperplastic Polyps
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2501 - 2508.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
M. Wrensch, K. T. Kelsey, M. Liu, R. Miike, M. Moghadassi, J. D. Sison, K. Aldape, A. McMillan, J. Wiemels, and J. K. Wiencke
ERCC1 and ERCC2 polymorphisms and adult glioma
Neuro-oncol, October 1, 2005; 7(4): 495 - 507.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. N. Silva, O. M. Gil, V. C. Oliveira, M. N. Cabral, A. P. Azevedo, A. Faber, I. Manita, T. C. Ferreira, E. Limbert, J. E. Pina, et al.
Association of Polymorphisms in ERCC2 Gene with Non-Familial Thyroid Cancer Risk
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2407 - 2412.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Broberg, J. Bjork, K. Paulsson, M. Hoglund, and M. Albin
Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer
Carcinogenesis, July 1, 2005; 26(7): 1263 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Han, G. A. Colditz, J. S. Liu, and D. J. Hunter
Genetic Variation in XPD, Sun Exposure, and Risk of Skin Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1539 - 1544.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Z. Abdel-Rahman, M. M. Ammenheuser, C. J. Omiecinski, J. K. Wickliffe, J. I. Rosenblatt, and J. B. Ward Jr.
Variability in Human Sensitivity to 1,3-Butadiene: Influence of Polymorphisms in the 5'-Flanking Region of the Microsomal Epoxide Hydrolase Gene (EPHX1)
Toxicol. Sci., May 1, 2005; 85(1): 624 - 631.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. B. Schabath, G. L. Delclos, H. B. Grossman, Y. Wang, S. P. Lerner, R. M. Chamberlain, M. R. Spitz, and X. Wu
Polymorphisms in XPD Exons 10 and 23 and Bladder Cancer Risk
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 878 - 884.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. E. Mechanic, A. J. Marrogi, J. A. Welsh, E. D. Bowman, M. A. Khan, L. Enewold, Y.-L. Zheng, S. Chanock, P. G. Shields, and C. C. Harris
Polymorphisms in XPD and TP53 and mutation in human lung cancer
Carcinogenesis, March 1, 2005; 26(3): 597 - 604.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Shen, M. D. Gammon, M. B. Terry, L. Wang, Q. Wang, F. Zhang, S. L. Teitelbaum, S. M. Eng, S. K. Sagiv, M. M. Gaudet, et al.
Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 336 - 342.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. Benhamou and A. Sarasin
ERCC2 /XPD Gene Polymorphisms and Lung Cancer: A HuGE Review
Am. J. Epidemiol., January 1, 2005; 161(1): 1 - 14.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Pavanello, A. Pulliero, E. Siwinska, D. Mielzynska, and E. Clonfero
Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers
Carcinogenesis, January 1, 2005; 26(1): 169 - 175.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Justenhoven, U. Hamann, B. Pesch, V. Harth, S. Rabstein, C. Baisch, C. Vollmert, T. Illig, Y.-D. Ko, T. Bruning, et al.
ERCC2 Genotypes and a Corresponding Haplotype Are Linked with Breast Cancer Risk in a German Population
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2059 - 2064.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Peluso, M. Neri, G. Margarino, C. Mereu, A. Munnia, M. Ceppi, M. Buratti, R. Felletti, F. Stea, R. Quaglia, et al.
Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms
Carcinogenesis, December 1, 2004; 25(12): 2459 - 2465.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. M. Brewster, A. J. Alberg, P. T. Strickland, S. C. Hoffman, and K. Helzlsouer
XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer
Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1271 - 1275.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Hao, H. Wang, K. Zhou, Y. Li, X. Chen, G. Zhou, Y. Zhu, X. Miao, W. Tan, Q. Wei, et al.
Identification of Genetic Variants in Base Excision Repair Pathway and Their Associations with Risk of Esophageal Squamous Cell Carcinoma
Cancer Res., June 15, 2004; 64(12): 4378 - 4384.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Vodicka, R. Kumar, R. Stetina, S. Sanyal, P. Soucek, V. Haufroid, M. Dusinska, M. Kuricova, M. Zamecnikova, L. Musak, et al.
Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA
Carcinogenesis, May 1, 2004; 25(5): 757 - 763.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. J. Hu, M. C. Hall, L. Grossman, M. Hedayati, D. L. McCullough, K. Lohman, and L. D. Case
Deficient Nucleotide Excision Repair Capacity Enhances Human Prostate Cancer Risk
Cancer Res., February 1, 2004; 64(3): 1197 - 1201.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Shen, R. J. Hung, P. Brennan, C. Malaveille, F. Donato, D. Placidi, A. Carta, A. Hautefeuille, P. Boffetta, and S. Porru
Polymorphisms of the DNA Repair Genes XRCC1, XRCC3, XPD, Interaction with Environmental Exposures, and Bladder Cancer Risk in a Case-Control Study in Northern Italy
Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1234 - 1240.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. R. Spitz, Q. Wei, Q. Dong, C. I. Amos, and X. Wu
Genetic Susceptibility to Lung Cancer: The Role of DNA Damage and Repair
Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 689 - 698.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. Matullo, M. Peluso, S. Polidoro, S. Guarrera, A. Munnia, V. Krogh, G. Masala, F. Berrino, S. Panico, R. Tumino, et al.
Combination of DNA Repair Gene Single Nucleotide Polymorphisms and Increased Levels of DNA Adducts in a Population-based Study
Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 674 - 677.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Zhou, G. Liu, D. P. Miller, S. W. Thurston, L. L. Xu, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani
Polymorphisms in the DNA Repair Genes XRCC1 and ERCC2, Smoking, and Lung Cancer Risk
Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 359 - 365.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
R. Kumar, S. Angelini, and K. Hemminki
Simultaneous detection of the exon 10 polymorphism and a novel intronic single base insertion polymorphism in the XPD gene using single strand conformation polymorphism
Mutagenesis, March 1, 2003; 18(2): 207 - 209.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. L. Goode, C. M. Ulrich, and J. D. Potter
Polymorphisms in DNA Repair Genes and Associations with Cancer Risk
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1513 - 1530.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. H. Phillips
Smoking-related DNA and protein adducts in human tissues
Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
S. Benhamou and A. Sarasin
ERCC2/XPD gene polymorphisms and cancer risk
Mutagenesis, November 1, 2002; 17(6): 463 - 469.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.